Shareholding disclosure

ADDEX THERAPEUTICS LTD

Declared position

35.93%

Threshold

Crossed downwards

Timeline

Published

24.05.2019

Transaction

17.05.2019

Transfer date

17.05.2019

Voting rights breakdown

Voting rights acquired19.84%
Voting rights sold35.93%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAJ5M00064

Beneficial owner

ADDEX THERAPEUTICS LTD

Declared address

ADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

Addex Pharma sa subscribed at 100% of the capital increase performed on May 17, 2019 (4'284'604 shares issued). Thresholds of 10% and 15% have been crossed on purchase position

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open